Several biotech and pharmaceutical companies are actively involved in researching and developing drugs for Parkinson’s disease. Parkinson’s disease is a neurodegenerative disorder that primarily affects movement. Efforts in this area range from developing therapies for managing symptoms to those targeting the disease’s underlying causes. Here are some notable companies and their approaches: ACADIA Pharmaceuticals: ACADIA…
Athira Pharma, Inc. (NASDAQ: ATHA), a leading late-stage biopharmaceutical company dedicated to pioneering small molecules that rejuvenate neurons and decelerate neurodegeneration, has unveiled compelling findings from its SHAPE Phase 2 clinical trial. This trial assessed the potential of fosgonimeton (ATH-1017) in patients grappling with Parkinson’s disease, dementia, and dementia with Lewy bodies. Fosgonimeton Fosgonimeton is a…
NATICK, MA, USA, October 31, 2023 /EINPresswire.com/ — NeuroDex, Inc. (“NeuroDex”, or the “Company”), announces that it has received a second grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), to study “Neuronal extracellular vesicles blood-based biomarker for lysosomal function.” This award will enable NeuroDex to utilize its unique ExoSORT™ platform to develop an…